IP Verse

Controlled Release Granular Compositions Containing Mesalazine And Process For The Manufacture Thereof - EP2461802

PATENT ANALYSIS

Patent Details

Grant Date
Aug 3, 2022
Company
SOFAR SPA
Oppositions

TILLOTTS PHARMA AG

More patents of Sofar Spa

EP2461802

Want to monitor this patent?

Feel free to send us a message here and we will get back to you